Diagnostic mutational analysis of MECP2 in Korean patients with Rett syndrome

In Joo Kim, Yeon Joo Kim, Byeong Hee Son, Sang Ook Nam, Hoon Chul Kang, Heung Dong Kim, Mi Ae Yoo, Ook Hwan Choi, Cheol Min Kim

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Rett syndrome (RTT) is an X-linked dominant neurodevelopmental disorder affecting 1 per 10,000-15,000 female births worldwide. The disease-causing gene has been identified as MECP2 (methyl-CpG-binding protein 2). In this study, we performed diagnostic mutational analysis of the MECP2 gene in RTT patients. Four exons and a putative promoter of the MECP2 gene were analyzed from the peripheral blood of 43 Korean patients with Rett syndrome by PCR-RFLP and direct sequencing. Mutations were detected in the MECP2 gene in approximately 60.5% of patients (26 cases/43 cases). The mutations consisted of 14 different types, including 9 missense mutations, 4 nonsense mutations and 1 frameshift mutation. Of these, three mutations (G161E, T311M, p385fsX409) were newly identified and were determined to be disease-causing mutations by PCR-RFLP and direct sequencing analysis. Most of the mutations were located within MBD (42.3%) and TRD (50%). T158M, R270X, and R306C mutations were identified at a high frequency. Additionally, an intronic SNP (IVS3 + 23C > G) was newly identified in three of the patients. IVS3 + 23C > G may be a disease-related and Korea-specific SNP for RTT. L100V and A201V are apparently disease-causing mutations in Korean RTT, contrary to previous studies. Disease-causing mutations and polymorphisms are important tools for diagnosing RTT in Koreans. The experimental procedures used in this study should be considered for clinical molecular biologic diagnosis.

Original languageEnglish
Pages (from-to)119-125
Number of pages7
JournalExperimental and Molecular Medicine
Volume38
Issue number2
DOIs
Publication statusPublished - 2006 Apr 30

Fingerprint

Methyl-CpG-Binding Protein 2
Rett Syndrome
Mutation
Genes
Restriction Fragment Length Polymorphisms
Single Nucleotide Polymorphism
Polymorphism
Exons
Blood
Polymerase Chain Reaction
Frameshift Mutation
Nonsense Codon
Missense Mutation
Korea
Parturition

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Kim, In Joo ; Kim, Yeon Joo ; Son, Byeong Hee ; Nam, Sang Ook ; Kang, Hoon Chul ; Kim, Heung Dong ; Yoo, Mi Ae ; Choi, Ook Hwan ; Kim, Cheol Min. / Diagnostic mutational analysis of MECP2 in Korean patients with Rett syndrome. In: Experimental and Molecular Medicine. 2006 ; Vol. 38, No. 2. pp. 119-125.
@article{68b29b7586194937bd0f8a1192d053cf,
title = "Diagnostic mutational analysis of MECP2 in Korean patients with Rett syndrome",
abstract = "Rett syndrome (RTT) is an X-linked dominant neurodevelopmental disorder affecting 1 per 10,000-15,000 female births worldwide. The disease-causing gene has been identified as MECP2 (methyl-CpG-binding protein 2). In this study, we performed diagnostic mutational analysis of the MECP2 gene in RTT patients. Four exons and a putative promoter of the MECP2 gene were analyzed from the peripheral blood of 43 Korean patients with Rett syndrome by PCR-RFLP and direct sequencing. Mutations were detected in the MECP2 gene in approximately 60.5{\%} of patients (26 cases/43 cases). The mutations consisted of 14 different types, including 9 missense mutations, 4 nonsense mutations and 1 frameshift mutation. Of these, three mutations (G161E, T311M, p385fsX409) were newly identified and were determined to be disease-causing mutations by PCR-RFLP and direct sequencing analysis. Most of the mutations were located within MBD (42.3{\%}) and TRD (50{\%}). T158M, R270X, and R306C mutations were identified at a high frequency. Additionally, an intronic SNP (IVS3 + 23C > G) was newly identified in three of the patients. IVS3 + 23C > G may be a disease-related and Korea-specific SNP for RTT. L100V and A201V are apparently disease-causing mutations in Korean RTT, contrary to previous studies. Disease-causing mutations and polymorphisms are important tools for diagnosing RTT in Koreans. The experimental procedures used in this study should be considered for clinical molecular biologic diagnosis.",
author = "Kim, {In Joo} and Kim, {Yeon Joo} and Son, {Byeong Hee} and Nam, {Sang Ook} and Kang, {Hoon Chul} and Kim, {Heung Dong} and Yoo, {Mi Ae} and Choi, {Ook Hwan} and Kim, {Cheol Min}",
year = "2006",
month = "4",
day = "30",
doi = "10.1038/emm.2006.15",
language = "English",
volume = "38",
pages = "119--125",
journal = "Experimental and Molecular Medicine",
issn = "1226-3613",
publisher = "Korean Society of Med. Biochemistry and Mol. Biology",
number = "2",

}

Diagnostic mutational analysis of MECP2 in Korean patients with Rett syndrome. / Kim, In Joo; Kim, Yeon Joo; Son, Byeong Hee; Nam, Sang Ook; Kang, Hoon Chul; Kim, Heung Dong; Yoo, Mi Ae; Choi, Ook Hwan; Kim, Cheol Min.

In: Experimental and Molecular Medicine, Vol. 38, No. 2, 30.04.2006, p. 119-125.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Diagnostic mutational analysis of MECP2 in Korean patients with Rett syndrome

AU - Kim, In Joo

AU - Kim, Yeon Joo

AU - Son, Byeong Hee

AU - Nam, Sang Ook

AU - Kang, Hoon Chul

AU - Kim, Heung Dong

AU - Yoo, Mi Ae

AU - Choi, Ook Hwan

AU - Kim, Cheol Min

PY - 2006/4/30

Y1 - 2006/4/30

N2 - Rett syndrome (RTT) is an X-linked dominant neurodevelopmental disorder affecting 1 per 10,000-15,000 female births worldwide. The disease-causing gene has been identified as MECP2 (methyl-CpG-binding protein 2). In this study, we performed diagnostic mutational analysis of the MECP2 gene in RTT patients. Four exons and a putative promoter of the MECP2 gene were analyzed from the peripheral blood of 43 Korean patients with Rett syndrome by PCR-RFLP and direct sequencing. Mutations were detected in the MECP2 gene in approximately 60.5% of patients (26 cases/43 cases). The mutations consisted of 14 different types, including 9 missense mutations, 4 nonsense mutations and 1 frameshift mutation. Of these, three mutations (G161E, T311M, p385fsX409) were newly identified and were determined to be disease-causing mutations by PCR-RFLP and direct sequencing analysis. Most of the mutations were located within MBD (42.3%) and TRD (50%). T158M, R270X, and R306C mutations were identified at a high frequency. Additionally, an intronic SNP (IVS3 + 23C > G) was newly identified in three of the patients. IVS3 + 23C > G may be a disease-related and Korea-specific SNP for RTT. L100V and A201V are apparently disease-causing mutations in Korean RTT, contrary to previous studies. Disease-causing mutations and polymorphisms are important tools for diagnosing RTT in Koreans. The experimental procedures used in this study should be considered for clinical molecular biologic diagnosis.

AB - Rett syndrome (RTT) is an X-linked dominant neurodevelopmental disorder affecting 1 per 10,000-15,000 female births worldwide. The disease-causing gene has been identified as MECP2 (methyl-CpG-binding protein 2). In this study, we performed diagnostic mutational analysis of the MECP2 gene in RTT patients. Four exons and a putative promoter of the MECP2 gene were analyzed from the peripheral blood of 43 Korean patients with Rett syndrome by PCR-RFLP and direct sequencing. Mutations were detected in the MECP2 gene in approximately 60.5% of patients (26 cases/43 cases). The mutations consisted of 14 different types, including 9 missense mutations, 4 nonsense mutations and 1 frameshift mutation. Of these, three mutations (G161E, T311M, p385fsX409) were newly identified and were determined to be disease-causing mutations by PCR-RFLP and direct sequencing analysis. Most of the mutations were located within MBD (42.3%) and TRD (50%). T158M, R270X, and R306C mutations were identified at a high frequency. Additionally, an intronic SNP (IVS3 + 23C > G) was newly identified in three of the patients. IVS3 + 23C > G may be a disease-related and Korea-specific SNP for RTT. L100V and A201V are apparently disease-causing mutations in Korean RTT, contrary to previous studies. Disease-causing mutations and polymorphisms are important tools for diagnosing RTT in Koreans. The experimental procedures used in this study should be considered for clinical molecular biologic diagnosis.

UR - http://www.scopus.com/inward/record.url?scp=33646810442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646810442&partnerID=8YFLogxK

U2 - 10.1038/emm.2006.15

DO - 10.1038/emm.2006.15

M3 - Article

C2 - 16672765

AN - SCOPUS:33646810442

VL - 38

SP - 119

EP - 125

JO - Experimental and Molecular Medicine

JF - Experimental and Molecular Medicine

SN - 1226-3613

IS - 2

ER -